D. Western Therapeutics Institute Inc
6DW
Company Profile
Business description
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
Contact
7th Floor, 18 KT Bulding
1-18-11, Nishiki, Naka-ku
Aichi
Nagoyashi460-0003
JPNT: +81 52218785
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
19
Stocks News & Analysis
stocks
Ask the analyst: Where does GYG stand following its US exit?
All roads lead back home for Guzman Y Gomez.
stocks
Chart of the Week: The long term headwinds facing copper shares
The key factors challenging the bull case for copper demand.
stocks
Australia’s oldest REIT undervalued
This REIT remains undervalued as trophy properties shine through.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,044.20 | 70.50 | 0.79% |
| CAC 40 | 8,474.86 | 137.57 | 1.65% |
| DAX 40 | 25,580.88 | 540.60 | 2.16% |
| Dow JONES (US) | 52,900.07 | 594.83 | 1.14% |
| FTSE 100 | 10,652.87 | 174.53 | 1.67% |
| HKSE | 23,371.19 | 316.16 | 1.37% |
| NASDAQ | 25,832.67 | 207.36 | -0.80% |
| Nikkei 225 | 69,243.68 | 510.53 | 0.74% |
| NZX 50 Index | 13,607.72 | 25.53 | 0.19% |
| S&P 500 | 7,483.24 | 0.01 | 0.00% |
| S&P/ASX 200 | 8,840.90 | 71.60 | 0.82% |
| SSE Composite Index | 4,057.11 | 28.21 | 0.70% |